Viemed Healthcare, Inc.

Stage 4 · Declining · week 3

As of Oct 22, 2026, Viemed Healthcare is in Stage 4, the downtrend phase, now in week 3 (since Oct 6, 2026). It closed at $9.92, 19.5% below its 52-week high and above its 200-day average, which is rising.

Viemed Healthcare, Inc., through its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services in the United States. More about the company

$9.92

+1.74% today

$378M · Small cap

Market Neutral — Building

Pro read

Pro

Our read

Declining, below its long-term trend

Setup score

—

Momentum

Accelerating ⇈

Edge

—

Is VMD early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…

Stage Cycle Timeline2023-08-16 → 2026-10-22

S4 15w

S4 21w

S2 34w

2023-08-162026-10-22

S1S2S3S4Setup score (0–10, dashed line at 5)

S3 1w → S4 15w → S1 12w → S2 8w → S3 6w → S4 12w → S1 7w → S2 10w → S3 12w → S4 21w → S1 5w → S4 1w → S1 4w → S4 6w → S1 2w → S2 34w → S3 6w → S4 2w current

Total tracked: 165 weeks across 18 stage runs.

VMD among Medical Devices18th of 141 by relative strength

All 141 →

Stocks in Medical Devices ranked by relative strength, with stage and one-month change
#	Stock	Stage	RS	1M
1	TXG10x Genomics, Inc.	Stage 2 · wk 48	99	−7.8%
2	RCELAvita Medical, Inc.	Stage 2 · wk 13	98	+40.8%
3	BFLYButterfly Network, Inc. Class A	Stage 2 · wk 26	98	−26.0%
4	HAEHaemonetics Corporation	Stage 2 · wk 17	96	+8.7%
5	GKOSGlaukos Corporation	Stage 2 · wk 25	96	+15.1%
6	AXGNAxogen, Inc.	Stage 3 · wk 2	95	−15.3%
7	NEOGNeogen Corporation	Stage 2 · wk 14	95	−11.7%
8	BVSBioventus Inc. Class A	Stage 2 · wk 15	95	+10.5%
…18	VMDViemed Healthcare, Inc.	Stage 4 · wk 3	84	+12.7%

vs 52W High

-19.5%

$6.26 lo$12.33 hi

19.5% below 52W high, ongoing decline

In Stage 4, distance from the 52-week high reflects an ongoing decline, not a discount.

Stage Maturity

Week 3

1w13w26w

Week 3, early Stage 4 decline

How long this stock has been in Stage 4 decline. The longer the downtrend, the more entrenched the selling pressure. No length of decline marks a bottom on its own.

vs 200 DMA

4.5%

200 DMA: $9.49 · rising

In Stage 4, the stock is below its 200-day average, the hallmark of a downtrend. Stage analysis waits for that to reverse before buying.

Rel Volume

0.48x

vs 50-day avg

High volume on down days in Stage 4 confirms institutional selling. Low-volume bounces are typical. They lack real buyers and are easy to mistake for reversals.

Trend Health

↑ ⇈

Short-term trend rising strongly, and accelerating

Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.

+12.7%

-15.7%

+4.5%

YTD

+37.4%

+45.2%

Scan Membership

Breakout Watch

Latest: 2024-10-24

7 appearances in last 60 days. First seen: 2020-05-29.

A stock that keeps qualifying week after week does so because its Stage 2 structure keeps holding. Staying power in the scan says more about the trend than any single appearance.

Recent Stage Timeline

2026-10-22S4

Wk 3 · Vol 0.48x

2026-10-21S4

Wk 3 · Vol 0.55x

2026-10-20S4

Wk 3 · Vol 0.56x

2026-10-19S4

Wk 2 · Vol 0.57x

2026-10-16S4

Wk 2 · Vol 0.98x

2026-10-15S4

Wk 2 · Vol 0.58x

2026-10-14S4

Wk 2 · Vol 0.61x

2026-10-13S4

Wk 2 · Vol 0.46x

2026-10-12S4

Wk 1 · Vol 0.40x

2026-10-09S4

Wk 1 · Vol 0.41x

2026-10-08S4

Wk 1 · Vol 0.72x

2026-10-07S4

Wk 1 · Vol 0.99x

Moving averages & range

50 DMA

$9.13

200 DMA

$9.49

52W High

$12.33

52W Low

$6.26

5D Low

$9.48

Resistance levels (recent highs)

20d High

$9.92

60d High

$11.76

120d High

$12.33

250d High

$12.33

Next resistance

+18.5%

to 60d High

P/E (TTM)

27.6

Forward 24.8

Earnings Growth (YoY)

-12.4%

Revenue +23.9%

ROE

+10.5%

Profit margin +4.8%

Dividend Yield

0.00%

P/B 2.6

Viemed Healthcare: quick answers

What stage is Viemed Healthcare in?

As of Oct 22, 2026, Viemed Healthcare (VMD) is in Stage 4, the downtrend phase. It entered Stage 4 on Oct 6, 2026 and is in week 3. What the four stages mean

Is Viemed Healthcare in an uptrend?

No. Viemed Healthcare is in a Stage 4 downtrend. It trades 4.5% above its 200-day average, which is rising.

How far is Viemed Healthcare from its 52-week high?

Viemed Healthcare closed at $9.92 on Oct 22, 2026, 19.5% below its 52-week high of $12.33. Its 52-week low is $6.26.

How has Viemed Healthcare performed over the past year?

As of Oct 22, 2026, Viemed Healthcare is up 45.2% over the past year and up 37.4% so far in 2026.

Which sector and industry is Viemed Healthcare in?

Viemed Healthcare is in the Medical Devices industry, part of the Health Care sector.

About this companyHealth Care· Medical Devices

Viemed Healthcare, Inc., through its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The company provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD. It also sells and rents HME devices, such as non-invasive and invasive ventilators, positive airway pressure (PAP) machines, durable medical equipment, percussion vests, oxygen concentrators, and other medical equipment. In addition, the company provides neuromuscular care and oxygen therapy services; and sleep apnea management which provides sleep solutions and/or equipment, such as PAP, automatic continuous positive airway pressure, and bi-level positive airway pressure machines. Further, it offers in-home sleep apnea testing services; and breast pumps and related lactation equipment and supplies, including fulfillment and support services, as well as healthcare staffing and recruitment services. Viemed Healthcare, Inc. was founded in 2006 and is headquartered in Lafayette, Louisiana.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.